Related Experiment Video
Updated: Jun 7, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Haemophilia in the German risk adjustment scheme]
1Abteilung Grundsatz und Risikostrukturausgleich, Barmer GEK, 42271 Wuppertal. pedro.ballesteros@barmer-gek.de
Hamostaseologie
|November 3, 2010
Summary
Haemophilia poses a significant risk adjustment challenge. Reintroducing expenditure-oriented risk sharing could improve Germany's healthcare financing system for rare, high-cost diseases.
Area of Science:
- Healthcare Economics
- Public Health Policy
Context:
- German risk adjustment schemes aim for cost-homogeneous groups.
- Current systems, including those from 2009 and 2010, inadequately address haemophilia.
- Haemophilia's extreme costs pose an existential threat to smaller health plans.
Purpose:
- To evaluate the inadequacy of the German risk adjustment scheme for haemophilia.
- To explore potential improvements for managing high-cost rare diseases within healthcare financing.
Summary:
- Haemophilia cases generate unpredictable, extreme costs, challenging existing risk adjustment models.
- The small patient population limits the effectiveness of detailed coding for creating cost-homogeneous subgroups.
- The current German system fails to account for haemophilia's unique cost structure.
Impact:
- Reinstating expenditure-oriented risk sharing is proposed as a solution.
- This approach aligns with international practices for managing rare, high-cost conditions.
- Improved risk adjustment can enhance the financial stability of health plans facing haemophilia cases.
Related Concept Videos
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...